You have no items in your shopping cart.
mTOR kinase Inhibitor 2
SKU: orb1298194
Description
Research Area
Pharmacology & Drug Discovery; Cell Biology
Images & Validation
−
Key Properties
−| CAS Number | 1021917-65-6 |
|---|---|
| MW | 369.42 |
| Purity | 99.97% (May vary between batches) |
| Formula | C19H23N5O3 |
| SMILES | C(N1C=2C(NC1=O)=NC=C(N2)C=3C=CC(C(C)(C)O)=NC3)C4CCOCC4 |
| Target | Others |
| Solubility | DMSO:50 mg/mL (135.35 mM) |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−2H Imidazo[4,5 b]pyrazin 2 one, 1,3 dihydro 6 [6 (1 hydroxy 1 methylethyl) 3 pyridinyl] 1 [(tetrahydro 2H pyran 4 yl)methyl] , 2HImidazo[4,5b]pyrazin2one, 1,3dihydro6[6(1hydroxy1methylethyl)3pyridinyl]1[(tetrahydro2Hpyran4yl)methyl]
Similar Products
−GNE-493 [orb1300013]
98.00% (May vary between batches)
1033735-94-2
372.44
C17H20N6O2S
1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)Voxtalisib [orb1300143]
99.69% (May vary between batches)
934493-76-2
270.29
C13H14N6O
10 mg, 1 mg, 100 mg, 2 mg, 5 mg, 25 mg, 50 mg, 1 ml x 10 mM (in DMSO)Polyphyllin I [orb1303595]
99.50% (May vary between batches)
50773-41-6
855.02
C44H70O16
10 mg, 5 mg, 25 mg, 50 mg, 100 mgVistusertib [orb1306966]
99.06% (May vary between batches)
1009298-59-2
462.54
C25H30N6O3
5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO), 200 mg, 1 mgPQR530 [orb1307857]
99.78% (May vary between batches)
1927857-61-1
407.42
C18H23F2N7O2
1 ml x 10 mM (in DMSO), 5 mg, 10 mg, 25 mg, 50 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.